EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis

Saima Shahid, Aisha Akhter

Medical Journal of South Punjab · 2025

DOI: 10.61581/mjsp.v5i01.375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Journal of South Punjab, 2025. Verfasst von Saima Shahid und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective: The study aims to compare the efficacy and safety of meglumine antimoniate and miltefosine in the treatment of cutaneous leishmaniasis in Pakistan. Methodology: This randomized-controlled trial was conducted at the Dermatology Departments of Pak Emirates Military Hospital Rawalpindi, Pakistan, from 10 July 2024 to 9 January 2025. Efficacy was graded on Day 28 as excellent (91-100% improvement), good (75-90%), fair (50-74%), or poor (

Zitieren

APA

Shahid, S., & Akhter, A. (2025). Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis. Medical Journal of South Punjab. https://doi.org/10.61581/mjsp.v5i01.375

Vancouver

Shahid S, Akhter A. Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis. Medical Journal of South Punjab. 2025. doi:10.61581/mjsp.v5i01.375

BibTeX
@article{Shahid2025,
  author = {Shahid, Saima and Akhter, Aisha},
  title = {Comparing the effect of Miltefosine and Meglumine Antimoniate in the treatment of Cutaneous Leishmaniasis},
  journal = {Medical Journal of South Punjab},
  year = {2025},
  doi = {10.61581/mjsp.v5i01.375}
}
Kostenlos starten →